Curriculum Vitae: Robert Jeremy West 18 November 2016
Undergraduate degree: BSc Psychology (1st Class), London University (1977)
Postgraduate degree: PhD Psychology, London University (1982)
Posts held
Sep1977 Sep 1979: UK Home Civil Service (Ministry of Defence)
Oct 1979 Jan 1982: Studying for PhD
Jan 1982 Sep 1985: Research Psychologist, Medical Research Council Addiction Research Unit, Institute of Psychiatry London University
Oct 1985 Sep 1989: Lecturer in Psychology, Royal Holloway and Bedford New College, London University
Oct 1989 - Aug1991: Senior Lecturer in Psychology, Royal Holloway and Bedford New College, London University
Sep 1991 - Sep1993 Senior Lecturer in Psychology, St George's Hospital Medical School, London University
Oct 1993 - Sep 1996: Reader, St George's Hospital Medical School, London University
Oct 1996 – Sep 2003: Professor of Health Psychology, St George's Hospital Medical School, London University
Oct 1998 - Aug 2003: Head of Psychology Department, St George’s Hospital Medical School, London University
Sep 2003- Professor of Health Psychology and Director of Tobacco Studies, Cancer Research UK Health Behaviour Unit, Department of Epidemiology and Public Health, University College London
Teaching
1. BSc in Psychology, Health Psychology Module (UCL)
2. DClinPsy Psychology (UCL)
3. MSc in Health Psychology, teaching a project supervision (UCL)
4. MSc in Cancer (UCL)
5. MSc in Social Epidemiology (UCL)
6. Behaviour Change Summer School (UCL)
7. Behaviour Change 3rd Year Module in Psychology (UCL)
8. MSc in Advanced Physiotherapy (UCL)
Editorships, committees and visiting professor positions
1. Addiction, Editor-in-Chief
2. National Centre for Smoking Cessation and Training, Co-director
3. Maastricht University, Visiting Professor
4. National Institute of Health and Care Excellence, Member of programme development groups
5. Society for Research in Nicotine and Tobacco, President (2011-2012)
6. QUIT, Trustee and honorary director
7. UK Society for Behavioural Medicine, Expert
8. SRNT/WHO Tobacco Treatment Database, Member of Editorial Board
9. Cochrane Collaboration Tobacco Review Group, Member of Editorial Board
PhD supervision and examining
· 17 completed as first supervisor (Ann McNeill, Jonathan Foulds, Janet Simpson, Clive Downs, James Elander, Michael Ussher, Kofi Krafona, Tony Wigram, Andy McEwen, Lion Shahab, Jenny Fidler, Elizabeth Holloway, Emma Beard, Miriam Armstrong, Bidyut Sarkar, Ildiko Tombor, Harveen Ubhi)
· 2 current as primary supervisor (Abdallaziz Alzahrane, Aleksandra Herbec), 3 as second supervisor (David Crane, Claire Garnett, Olga Perski)
· 16 PhDs examined
Knowledge translation and public engagement
· Advisor to Department of Health Tobacco Policy Team: helped set up national network of stop-smoking services; regular input to decision making on the full range of policy issues from harm reduction to pricing and standard packaging using data from the Smoking Toolkit Study and other sources
· Advisor to Public Health England Communications Team: helped design and establish Stoptober campaign and overall communications strategy since 2008; regular input to communications policy, ongoing collaboration on development and implementation of digital interventions to promote and aid cessation (e.g. StopAdvisor), ongoing provision of key data on smoking and smoking cessation from The Smoking Toolkit Study to evaluate campaigns and model elements of the communications strategy
· Advisor to Medicines and Healthcare Regulatory Authority: regular input to decision making on issues from licensing of nicotine products to changes in indications, primarily using data from the Smoking Toolkit Study
· Advisor to English NHS Stop-Smoking Services: continued advice and free consultancxy to the services on a near daily basis with regard to configuration of services, type of behavioural support provided and medication options
· Founder and Honorary Co-Director of National Centre for Smoking Cessation and Training: responsible for knowledge transfer and evaluation (this organisation was set up by the DH and has trained 16,000+ stop smoking advisors, treating some 700,000 smokers per year)
· Trustee of the stop-smoking charity, QUIT: responsible for knowledge transfer and quality control
· Member of NICE Programme Development committees: helped produce guidance on brief advice, behyaviour change, stop-smoking services, and tobacco harm reduction
· Training stop smoking advisors in UK, Canada, China, and the Middle East
· Editorial board of Treatobacco.net, a global resource of health professionals on effective treatments for tobacco dependence
· Author of ‘The SmokeFree Formula (Orion)’ a book that aims to bring the science of stopping to smokers, launched in December 2013 with translation contracts agreed so far in Spanish, Russian, Dutch, Norwegian, Romanian, Turkish, French, Italian and German
· Regular (at least monthly) television, radio, newspaper and magazine interviews for UK and overseas media
Enablement
· Mentoring and supervision of clinicians, postgraduate students and researchers in Argentina, China, Germany, India, Italy, Malaysia, Nigeria, Portugal, Taiwan, The Czech Republic, The Netherlands, Uruguay: this includes setting up and supervising joint projects, hosting visiting academics, clinicians and students and overseas visits for discussions and supervision.
Research grants and contracts
Completed
1. West, R., Wilding, J. Department of Transport. Effects of alcohol on drivingrelated tasks. £11,500. 1987.
2. West, R., Wilding, J. Eysenck, M. Department of Transport. Cognitive factors in accident liability. £127,000. 198891.
3. West, R., Wilding, J. Department of Transport. Effects of alcohol on drivingrelated tasks. £23,000. 198788.
4. West, R. Department of Transport. Acceptability of an automated route guidance system. £12,700. 198889.
5. West, R. Department of Transport. Acceptability of an automated route guidance system. £2,500. 198889.
6. West, R. BristolMyers Pharmaceuticals. Effects of buspirone on cigarette withdrawal symptoms. £22,100. 198889
7. West, R. Department of Transport. Acceptability of an automated route guidance system. £9,900. 1989.
8. Hajek, P., West, R. Wellcome Trust. Stability of nicotine intake, responsiveness to nicotine and personality in occasional smokers. £15,300. 1989-1991.
9. West, R., West, A., Sammons, P. Department of Transport. Monitoring the General Accident and Eastern Region Traffic Club. £65,300. 1990-1991.
10. West, R. Department of Transport. Classification of traffic accidents. £25,000. 1991-1992
11. West, R., Hajek, P. Glaxo Group Research. Effects of ondansetron on ability to achieve and sustain abstinence from cigarettes. £139,000. 1991-1993.
12. West, R. Department of Transport. Assessing the future accident liability of learner drivers. £119,000. 1992-94.
13. West, R. Department of Transport. Cross cultural study of accident liability. £1,600. 1992-93.
14. West, R. Department of Transport. Consistency in involvement in different types of accident. £7,800. 1992-93.
15. West, R. British Petroleum. Accident liability of tanker drivers. £5,600. 1992-93.
16. West, A., West, R. Association of London Authorities. Additional Educational Needs Assessment: Options for Change. £6,300. 1993
17. West, R. Department of Transport. Analysis of accident involvement of novice drivers. £8,000. 1994.
18. Jarvik, M., West, R. American Cancer Society. Oral glucose as an aid to smoking cessation. $120,000 1994-1996.
19. West, R., Hajek, P. Department of Health . Use of a 'buddy system' to aid smoking cessation in primary care. £18,000 1994-1996.
20. West, R., Junger, M., West, A., Taylor, E., Pickering, A. Department of Transport. Risk taking in children and its relationship with problem behaviour. £192,000 1995-1997.
21. Hajek, P., West, R., Foulds, J. Department of Health and Health Education Authority. Helping pregnant women stop smoking: a controlled trial of a brief multi-modal intervention package. £160,000 1995-1998.
22. Foulds, J., West, R. World Bank. A population-based anti-smoking campaign in Hungary. £58,000 1995-1998.
23. West, R. Department of Transport. Accident script analysis of insurance company claims. £11,000. 1995.
24. West, R. Wellcome Trust. Oral glucose as an aid to smoking cessation. £70,000. 1995-1997.
25. Hajek, P., West, R., Foulds, J. Pharmacia&Upjohn. Comparison of nicotine replacement products. £138,000. 1995-1998.
26. West, A., Travers, A., West, R. ESRC. Financing Education. £120,000. 1996-1998
27. West, R., Raw, M. Clinical guidelines for smoking cessation. Health Education Authority, £15,000. 1997
28. West, R. Feasibility of implementing a ‘buddy’ system in routine general practice smoking cessation services. Department of Health. £10,000. 1997.
29. West, R. Randomised trial of nicotine/mecamylamine patch in smoking cessation. Sano Corporation. £125,000. 1998-1999.
30. West, R. Hajek, P Randomised trial of oral dextrose in smoking cessation. Wellcome Trust. £260,000. 1998-2002.
31. West, R. National survey of GP smoking cessation activities. Health Education Authority. £20,000. 1998-2000.
32. West, R. Analysis of national smokers recall survey follow-up. Health Education Authority. £13,000. 1998-1999.
33. West, R. Hospital nicotine replacement trial. Pharmacia and Upjohn, £66,000. 1999-2000.
34. West, R., Steptoe, A., Taylor, A., Ussher, M., McEwen, A. A randomised trial of a tailored physical activity intervention in smoking cessation. Cancer Research Campaign, £110,000. 1999-2001.
35. West, R. Updating smoking cessation guidelines. Health Education Authority, £5,000, 1999-2000.
36. West, R. Mapping smoking cessation training in the UK. Health Development Agency, £6,500, 2001.
37. West R. Treatment guidelines for smokeless tobacco dependence. Health Development Agency, £13,500. 2001-2002.
38. McEwen, A. West, R. Pilot study on recruiting pregnant smokers into treatment services. Merton Sutton and Wandsworth Health Authority. £32,000. 2001-2002.
39. Hajek, P. West, R. Effect of nicotine gum on withdrawal symptoms during temporary abstinence. Pharmacia, £50,000. 2002
40. West R. Randomised trial of a tailored web-based package to aid smoking cessation. GSK, £7,500, 2003.
41. West R, McNeill A, Owen L. Helping PCTs meet their smoking cessation targets. Department of Health, £13,000, 2004.
42. West R, McNeill A. Assessing intake of TSNAs from cigarettes with different nominal yields. Department of Health, £24,000, 2004.
43. Powell, J., Powell, J., Pickering, A., West, R. Alterations in motivation, response inhibition and dopamine transmission in smokers across three months of abstinence. NIH, $225,000, 2002-2005 (Award number: R21 DA14116-01)
44. Arnott D, Stead L, McNeill A, Coleman T, West R. National Institute of Clinical and Health Excellence. Rapid review on brief interventions for smoking cessation. NICE. £30,000, 2005.
45. Arnott D, McNeill A, Raw M, West R. Guidance on MHRA indications for use of nicotine replacement therapy. Department of Health. £10,000, 2005.
46. West R, Feasibility study for development of a national cohort of smokers: the Smoking Toolkit. Cancer Research UK, £29,000, 2005-2006. (Award number: C1417/A5828)
47. Stapleton J, Sutherland G, Hajek P, West R. Effectiveness of nicotine replacement therapy versus Zyban in smoking cessation. MRC, £551,000, 2003-2006 (Award number PAABHOA)
48. West R. Contribution to Smoking Toolkit Study. GlaxoSmithKline. £176,250, 2006-2007.
49. West R, Analysing data and writing up papers arising from the ATTEMPT cohort study. Sanofi-Synthelabo, €10,000, 2004-2008.
50. West R, Vangeli E. An in-depth investigation of the causes and process of relapse to smoking. Cancer Research UK. £39,000, 2006-2008.
51. West R, Contribution to Smoking Toolkit Study. Pfizer £170,000, 2007-2008
52. West R, Contribution to Smoking Toolkit Study. GlaxoSmithKline. £50,000, 2008.
53. Ussher M, Aveyard P, Evans P, Hucklebridge F, Ibison J, Reid F, Steptoe A, West R The effect of hydrocortisone on desire to smoke and tobacco withdrawal symptoms Cancer Research UK £34,885, 2007-2008 (Award number C8641/A8419)
54. West R. Contribution to Smoking Toolkit Study. Pfizer Consumer Healthcare. £150,000, 2006-2007.
55. West R, Zatonski W, Cedzynska M, Aveyard P, Stapleton J. Tabex Smoking Cessation (TASC) trial. NPRI/MRC. £215,000, 2006-20010.
56. Aveyard P, West R. Rapid reduction versus abrupt quitting for smokers who want to stop soon: a randomised controlled non-inferiority trial. British Heart Foundation £151,701 2008-2010 (Award number PG/08/047/25082)
57. West R, Wardle J. Smoking cessation: population and clinical approaches. Cancer Research UK. £2,850,000, 2007-2012 (Award number C1418/A7972)
58. West R Contribution to the Smoking Toolkit Study. Department of Health £690,000 2009-2012.
59. Ussher M, Aveyard P, Coleman T, Marcus B, Barton P, Manyonda I, Lewis B, West R A pragmatic randomized controlled trial of physical activity as an aid to smoking cessation during pregnancy National Institute for Health Research, Health Technology Assessment. £1,182,613, 2008-2012.
60. Britton J, McNeill A, Aveyard P, Bauld L, Hastings G, Hajek P, West R. The UK Centre for Tobacco Control Studies. UKCRC £5,000,000, 2008-2013.
61. Michie S, West R, McEwen A. NHS Centre for Smoking Cessation and Training. Department of Health £3,000,000 2009-2012.
62. West R. Systematic review and recommendations on affordable treatments for smoking cessation. Society for the Study of Addiction. £25,000, 2011-2012.
63. West R, Michie S, McEwen A, Stapleton J, Gardner B, Yardley L, Wills G Development and evaluation of an online smoking cessation support system. NPRI/MRC. £452,000, 2009-2013
64. West R. Comparison between varenicline and NRT on safety and efficacy in clinical practice. Pfizer, £39,000, 2011-2012.
65. Bonevski B, Paul C, Girgis A, D’Este C, West R. RCT of a caseworker delivered smoking cessation intervention for a socially disadvantaged population. NHMRC AU$500,000, 2010-2014
66. West R, McNeill A, Gilmore A. Price paid for cigarettes and tobacco and its association with smoking cessation. Cancer Research UK. £48,000, 2012-2015. (C1417/A15631)
Current
67. West R, Michie S, McNeill A, Aveyard P. Smoking cessation: population and clinical approaches. Cancer Research UK. £1,655,000, 2012-2017 (C1417/A14135).
68. Pokhrel S, Boehler C, Lester-George A, Kelly M, Morgan A, Owen L, Leidl R, Vogl M, Trapero-Bertran M, Lopez-Casasnovas G, Kalo Z, Helter T, Evers S, de Vries H, Crossifled A, Andrews F, Rutter A, West R European study on quantifying utility of investment in protection from tobacco (EQUIPT). European Union FP7-HEALTH-2013-INNOVATION-1. Euros 2,047,908.00, 2013-2016 (Grant number 602270).
69. Britton J, et al (2013) UK Centre for Tobacco and Alcohol Studies. UK CRC. £3,601,200, 2013-2018.
Publications
Peer reviewed publications in journals
1. Cross I, Howell P and West R (1983) Preferences for scale structure in melodic sequences. Journal of Experimental Psychology: Human Perception and Performance, 9, 444460.
2. Howell P, West R and Cross I (1984) The detection of notes incompatible with scalar structure. Journal of the Acoustical Society of America, 76, 16891692.
3. Devitt G, West R and Jarvis M (1984) Test for assessing tar/nicotine yields. American Journal of Public Health, 74, 391.
4. West R, Jarvis M, Russell M, Carruthers M and Feyerabend C (1984) Effect of nicotine replacement on the cigarette withdrawal syndrome. British Journal of Addiction, 79, 215219.
5. West R, Russell M, Jarvis M and Feyerabend C (1984) Does switching to an ultralow nicotine cigarette induce nicotine withdrawal effects? Psychopharmacology, 84, 120123.